glp-1 class diabetes drugs What to Make of the Coverage and Cost Landscape GLP-1 drugs likely to be
Description
PMID: 24678906
W.AstrupA.FujiokaK.GreenwayF.LauD
Most patients notice appetite reduction within the first few weeks
Tan Q, Akindehin SE, Orsso CE, et al
The rise in insulin with the decrease in glucagon was associated with lower fasting glucose concentrations and reduced glucose excursion following an oral glucose load or a meal
